Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9071|88|12|2044-2051

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.88, Iss.12, 2016-12, pp. : 2044-2051

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Viral Drugs for Human Adenoviruses

By Waye Mary Miu Yee   Sing Chor Wing  

Pharmaceuticals, Vol. 3, Iss. 10, 2010-10 ,pp. : 3343-3354

MDPI

Access to resources Recommend Favorite

Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element

By Marton Soledad   Berzal-Herranz Beatriz   Garmendia Eva   Cueto Francisco J.   Berzal-Herranz Alfredo  

Pharmaceuticals, Vol. 5, Iss. 1, 2011-12 ,pp. : 49-60

MDPI

Access to resources Recommend Favorite

Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti‐HCV combination therapy

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 1, 2016-01 ,pp. : 86-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

Classification of HCV NS5B Polymerase Inhibitors Using Support Vector Machine

By Wang Maolin   Wang Kai   Yan Aixia   Yu Changyuan  

International Journal of Molecular Sciences, Vol. 13, Iss. 4, 2012-03 ,pp. : 4033-4047

MDPI

Access to resources Recommend Favorite

Effects of Intermediates between Vitamins K2 and K3 on Mammalian DNA Polymerase Inhibition and Anti-Inflammatory Activity

By Mizushina Yoshiyuki   Maeda Jun   Irino Yasuhiro   Nishida Masayuki   Nishiumi Shin   Kondo Yasuyuki   Nishio Kazuyuki   Kuramochi Kouji   Tsubaki Kazunori   Kuriyama Isoko   Azuma Takeshi   Yoshida Hiromi   Yoshida Masaru  

International Journal of Molecular Sciences, Vol. 12, Iss. 2, 2011-02 ,pp. : 1115-1132

MDPI

Access to resources Recommend Favorite